27
24
2
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T36125 | Tienilic Acid | P450 | |
Tienilic Acid is a uricosuric diuretic with certain hepatotoxicity | |||
T37906 | Dibenamine hydrochloride | Adrenergic Receptor | |
Dibenamine hydrochloride is a competitive and irreversible blocking agent of the β-adrenergic receptor. | |||
T0840 | Methimazole | Tapazole,Thiamazole | Thyroid hormone receptor(THR) |
Methimazole (Thiamazole) is an antithyroid compound with significant hepatotoxicity and is often used in the study of hyperthyroidism. | |||
T7747 | Datelliptium chloride hydrochloride | DNA/RNA Synthesis | |
Datelliptium chloride hydrochloride is a DNA-intercalating agent derived from ellipticine. with anti-tumor activities. | |||
T13231L | Trovafloxacin mesylate | Others , DNA/RNA Synthesis , Topoisomerase , Antibacterial | |
Trovafloxacin is a broad-spectrum fluoroquinolone antibiotic that inhibits the activity of DNA gyrase and topoisomerase IV, enzymes involved in DNA replication. It also acts as an effective and specific inhibitor of the ... | |||
T21439 | Tacrine | CS 12602,Tacrinum,Tetrahydroaminocrine | AChR |
Tacrine (CS 12602) is an indirect cholinergic agonist and centrally acting anticholinesterase. It is approved for the treatment of Alzheimer's disease. | |||
T8845 | UTL-5g | 3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-,GBL-5g | TNF |
UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hemat... | |||
T1090 | Perphenazine | Perphenazin,Etaperazine,Trilafon | CaMK , Dopamine Receptor , 5-HT Receptor , Adrenergic Receptor , Histamine Receptor |
Perphenazine (Trilafon) is a phenothiazine derivative and a dopamine antagonist with antiemetic and antipsychotic properties. | |||
T13231 | Trovafloxacin | DNA gyrase , Topoisomerase , Antibacterial , Antibiotic | |
Trovafloxacin is a broad-spectrum quinolone antibiotic with potent activity against Gram-positive. | |||
T67509 | Cholesteryl Hemisuccinate | Cholesterol hydrogen succinate | Apoptosis , DNA/RNA Synthesis , Topoisomerase |
Cholesteryl Hemisuccinate (Cholesterol hydrogen succinate) is a highly soluble cholesterol analogue often used in polar solutions for its hepatoprotective, anticancer and tumour growth inhibiting properties. Cholesteryl ... | |||
TF0106 | Cholesteryl Hemisuccinate Tris Salt | Apoptosis | |
Cholesteryl Hemisuccinate Tris Salt is an acidic cholesteryl ester with hepatoprotective and anticancer activity.Cholesteryl hemisuccinate is a membrane stabilizer in dipalmitoylphosphatidylcholine liposomes containing C... | |||
T33707 | N-Nitrosofenfluramine, (S)- | J1.936.463A | |
N-Nitrosofenfluramine is a compound that is thought to cause hepatotoxicity in subjects. | |||
T69613 | Ar-H047108 free base | ||
Ar-H047108 free base is an imidazopyridine potassium competitive acid blocker (P-CAB). This drug may be used to treat early stellate cell activation and veno-occlusive-disease (VOD)-like hepatotoxicity. | |||
T31043 | CP-199330 | UNII-V4WYK6T8QA,CP 199330,UNII-74573Q728X,CP-199330 sodium | |
CP-199330 is a cysteyl LT1 receptor antagonist with no hepatotoxicity and is equivalent to the commercially available CYSLT1 receptor antagonists Zafirlukast and Pranlukas. | |||
T71358 | Nialamide monohydrochloride | ||
Nialamide monohydrochloride is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant. It was withdrawn by Pfizer several decades ago due to the risk of... | |||
T38312 | L-Cysteine-glutathione disulfide | ||
L-Cysteine-glutathione disulfide, a glutathione derivative endogenous to mammalian cells, is comprised of the oxidized form of free glutathione tripeptide linked via a disulfide bond to L-cysteine. It has been shown to p... | |||
T62057 | Anticancer agent 12 | ||
Anticancer agent 12 shows cytotoxic activity in malignant cells with no hepatotoxicity. | |||
T60771 | Metamizol | ||
Metamizol (Methamizole) blocks thyroid hormone production from the thyroid gland which is an anti-thyroid agent. However, Metamizol has hepatotoxicity as adverse effect [1]. | |||
T36837 | (E,Z)-2-propyl-2-Pentenoic Acid | ||
(E,Z)-2-propyl-2-Pentenoic acid is a bioactive metabolite of valproic acid that exhibits the same profile and potency of anticonvulsant activity in animal models as its parent compound without any observed teratogenicity... | |||
T83050 | Anti-inflammatory agent 62 | ||
Anti-inflammatory agent 62 mitigates acetaminophen-induced hepatotoxicity in HepG2 cells by modulating inflammatory and oxidative stress pathways [1]. | |||
T37463 | CAY10704 | ||
CAY10704 is a potent inhibitor of hepatitis C virus (HCV) infection (EC50 = 17 nM) that displays low cytotoxicity of virally-infected human hepatoma Huh7.5.1 cells (CC50 = 21.3 μM). It displays good pharmacokinetics in m... | |||
T38206 | 3-Cysteinylacetaminophen (trifluoroacetate salt) | APAP-Cys,3-(cysteine-S-yl)acetaminophen,3-Cysteinylacetaminophen (trifluoroacetate salt) | |
3-Cysteinylacetaminophen is an acetaminophen-protein adduct formed during the metabolism of acetaminophen.[1],[2] 3-Cysteinylacetaminophen has been found in isolated human serum following therapeutic and supratherapeutic... | |||
T73245 | AChE-IN-9 | ||
AChE-IN-9, a Tacrine glycoconjugate connected to acetylated β-Glucose, acts as an AChE inhibitor, demonstrating an IC 50 value of 0.4 μM and exhibiting reduced hepatotoxicity in healthy cells. This compound finds use in ... | |||
T73255 | Akt1-IN-1 | ||
Akt1-IN-1 is a potent and selective inhibitor of Akt1, demonstrating an IC50 of 18.79 nM in MIA PaCa-2 cells, indicating its high efficacy in inhibiting this specific kinase. Notably, it shows no significant teratogenici... | |||
T74717 | 12-Hydroxynevirapine | ||
12-Hydroxynevirapine (12-hydroxy-NVP; 12-OH-NVP), a significant oxidative metabolite of Nevirapine—an antiviral drug used for HIV-1 infections known for potential idiosyncratic hepatotoxicity and skin rashes—undergoes bi... | |||
T62822 | CT1-3 | ||
CT1-3 is a potent anti-cancer agent. CT1-3 regulates the JNK/Bcl-2/Bax/XIAP pathway, which induces mitochondria-mediated apoptosis. CT1-3 regulates the E-cadherin/Snail axis to inhibit epithelial mesenchymal transition (... | |||
T79454 | Anti-NASH agent 1 | PPAR | |
Anti-NASH Agent 1 (Compound 3d), derived from Elafibranor, serves as a strong PPAR-α/δ agonist aimed at treating nonalcoholic steatohepatitis (NASH). At dosages of 3-10 mg/kg over four weeks, this compound ameliorates hy... |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T4S0790 | Diosbulbin B | Others | |
1. Diosbulbin B exhibits potential hepatotoxicity. 2. Diosbulbin B has potential anti-tumor effects which may be related to influencing the immune system for the first time. | |||
T3913 | Saikosaponin D | Estrogen Receptor/ERR , NF-κB , Antibacterial , STAT | |
Saikosaponin D is a novel SERCA inhibitor by inhibiting NF-κB and STAT3 signaling to protect against acetaminophen-induced hepatotoxicity. | |||
T6S0234 | Toosendanin | Others | |
1. Toosendanin possesses hepatotoxicity. 2. Toosendanin has effects on the growth, cell cycle arrest, induction of apoptosis and the involved signaling pathway in human promyelocytic leukemia HL-6 cells. 3. Toosendanin i... | |||
T7036 | 2,4'-Dihydroxybenzophenone | Antioxidant | |
2,4'-Dihydroxybenzophenone can effectively protect C57BL/6J mice from APAP-induced hepatotoxicity. Its mechanisms might be associated with its Antioxidant activity. | |||
T3999 | D(+)-Galactosamine hydrochloride | D-Galactosamine HCl | Others |
D(+)-Galactosamine hydrochloride (D-Galactosamine HCl) hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice. | |||
T5S0285 | Cistanoside A | Others | |
1. Cistanoside A possesses protective activities on CCl4 induced hepatotoxicity in mice, which is involved with increasing free radicals clearing activities, alleviating lipid-overoxidation damage, and improving respirat... | |||
T6S2246 | Alisol B 23-acetate | Alisol B Acetate,Alisol B monoacetate,23-O-Acetylalisol B,23-Acetylalismol B | Others |
1. Alisol B 23-acetate (Alisol B Acetate) produces protective effect against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes. 2. Alisol B 23-acetate produces promotiv... | |||
TWS1977 | Kamebakaurin | Kamebakaurine | NF-κB |
1. Kamebakaurin (Kamebakaurine) has the ability to protect the liver from APAP-induced hepatotoxicity, presumably by both inhibiting the inflammatory response and oxidative stress. 2. Kamebakaurin inhibits the expression... | |||
T4S2326 | Cornuside | 7-Galloylsecologanol,7-O-Galloylsecologanol,Comuside | ERK , p38 MAPK , NF-κB , JNK |
1. Cornuside (Comuside) has immunomodulatory activity . 2. Cornuside suppresses expression levels of cytokine-induced proinflammatory and adhesion molecules in the human endothelial cells. 3. Cornuside can treat myocardi... | |||
T20635 | Senkirkin | Renardin | |
Senkirkin is a pyrrolizidine alkaloid with hepatotoxicity. | |||
TN3871 | Diosbulbin C | Others | |
Diosbulbin C has hepatotoxicity. | |||
TN1588 | Dihydroisotanshinone I | ATPase , Potassium Channel , Calcium Channel | |
Dihydroisotanshinone I has protective action against menadione-induced hepatotoxicity, attributed to its antioxidant properties including the free radical scavenging activity and inhibition of lipid peroxidation. | |||
TN4513 | Meliasenin B | Others | |
Meliasenin B may cause hepatotoxicity, it displays dose-dependent toxicity on HepG2 cells. | |||
TN1670 | Ganodermanondiol | HIV Protease , Nrf2 , AMPK | |
Ganodermanondiol exhibits potent cytoprotective effects on t-BHP-induced hepatotoxicity in human liver-derived HepG2 cells, presumably through Nrf2-mediated antioxidant enzymes and AMPK. | |||
T81795 | Microcystin-WR | ||
Microcystin-WR, a hepatotoxic metabolite derived from cyanobacteria, has been demonstrated to induce hepatotoxicity in mice [1]. | |||
TN5278 | Zederone | NADPH-oxidase , P450 , TNF , Nrf2 , Antifection | |
Zederone has anti-bacterial activity,it inhibits gram-positive bacteria activity. Zederone induces hepatotoxicity implicated the induction of Cyps, which leads to the formation of biological reactive metabolites and that... | |||
TN3412 | Andrographiside | Others | |
Andrographiside shows protective effects on hepatotoxicity induced in mice by carbon tetrachloride or tert-butylhydroperoxide (tBHP) intoxication, the effects could be due to its glucoside groups which may act as strong ... | |||
TN5336 | 9-Oxo-10,11-dehydroageraphorone | 4,7(11)-Cadinadiene-3,8-dione,DTD,7,11-Dehydro-8-oxoageraphorone | |
9-Oxo-10,11-dehydroageraphorone has acaricidal activity. It induces hepatotoxicity and cholestasis in rats. 9-Oxo-10,11-dehydroageraphorone also effectively inhibits the proliferation of HeLa cells by arresting the cell ... | |||
TN1478 | Celosin I | Others | |
Celosin H, celosin I, and celosin J could be used as chemical markers for the quality control of C. argentea seeds. Celosin I exhibited significant hepatoprotective effect on carbon tetrachloride-induced and N,N-dimethyl... | |||
T82310 | Glomeratide A | ||
Glomeratide A, a benzophenone C-glucoside, exhibits hepatoprotective properties and safeguards rat liver epithelial stem-like cells from d-galactosamine-induced hepatotoxicity. | |||
T82748 | Celosin L | ||
Celosin L, a triterpenoid saponin, demonstrates hepaprotective activity and exerts protective effects against APAP-induced hepatotoxicity in HepG2 cells [1]. | |||
T82219 | Heilaohuguosu F | ||
Compound 6, known as Heilaohuguosu F, is a tetrahydrofuranolignan demonstrating weak hepatoprotective properties. It exhibits a mild protective effect against acetaminophen (APAP)-induced hepatotoxicity in HepG2 cells. | |||
TN4223 | Homopterocarpin | Antifection | |
Homopterocarpin and Pterocarpus extract offer gastroprotection against indomethacin- induced ulcer by antioxidative mechanism and the modulation of gastric homeostasis, homopterocarpin may be responsible for, or contribu... | |||
T37770 | Taurohyodeoxycholic acid | ||
Taurohyodeoxycholic acid (THDCA) is a taurine-conjugated form of the secondary bile acid hyodeoxycholic acid .1THDCA decreases the size and weight of human gallstonesin vitro. It increases bile flow, biliary cholesterol ... |
カタログ番号 | 製品名 | ||
---|---|---|---|
L5510 | Drug-induced Liver Injury (DILI) Compound Library | 1001 compounds | |
A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening; | |||
L8700 | Ferroptosis Compound Library | 779 compounds | |
A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study; |